Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8977 - 8984 of 12089 results
MA Health Policy Updates - Moves to Strengthen HPC and Expand Telemedicine
November 2, 2015| Blog| Viewpoint
Data Breach Planning in 10 Easy Steps: How to Think Like A Litigator
November 2, 2015| Blog| Viewpoint
Corporate Divorce Series: An Employment Relationship Fail
October 30, 2015| Blog| Viewpoint
New York State Employers Face Strict New Equal Pay and Sex Discrimination Laws
October 30, 2015| Blog| Viewpoint
Data-Harvesting Zombie Hackers, Blood-Thirsty Auditors, and Other Reasons to be Scared on Halloween
October 30, 2015| Blog| Viewpoint
Skeletons in the Closet? Beware of Potential Enforcement Actions
October 29, 2015| Blog| Viewpoint
Policy and Legal Implications of Implementing Renewable Energy at Scale: Renewables Intermittent Power Generation (Part 6 of 6)
October 28, 2015| Blog| Viewpoint
Ray Cotton Named to Best Lawyers in America 2016!
October 28, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|